Today, Cramer came on CNBC for the STOP TRADING segment and was briefly positive on Olin Corporation (NYSE: OLN) as a cheap chemical company and positive on Churchill Downs, Inc. (NASDAQ: CHDN) ahead of the Kentucky Derby.
The main issue though is on Crocs, Inc. (NASDAQ: CROX). Cramer is still sticking with Crocs as one that is now not a fad, and he thinks it is going higher.
He did not go as far as a $95.00 target that was given today but he is now saying the ugly shoes are "not a fad." That is markedly different than what he noted in February when he said you could still make money before the fad peaks and it tumbles. He noted somewhat jokingly that Liz Claiborne, Inc. (NYSE: LIZ) ought to go buy that company to re-energize its sagging brand. So that may be a key change in his longer-term views and sounds like he's going to be behind this one for longer than just "a trade" for his future shows and appearances.
Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in any of the companies he covers.
Last updated: May 16, 2012: 09:49 AM
Hot Stocks
DailyFinance Headlines
- The Truth About JPMorgan Chase's $2 Billion Loss: It's No Big Whoop
- Hollywood, Homeland Security Double Up Video Piracy Warnings
- GM Kills $10 Million Facebook Ad Campaign Because It Didn't Work
- Saver or Sensualist, Innocent or Vigilant: What's Your Money Type?
- ExxonMobil's Safety Obsession: Inside the Mind of an Oil Giant
Benzinga Headlines
- Sears to Shed Clothing
- Is Cisco About to Buy NDS?
- Current Account, Import Prices Says US is Buying Goods on the Cheap
- Goldman Sachs Executive Director Calls the Bank "Toxic" on the Way Out
- BB&T Acquires BankAtlantic
TheFlyOnTheWall.com Headlines
- Diamonds Fund ETF: Pivot points
- Fossil moves up in early trading, resistance is at $75.54
- Dick's Sporting shares should be bought at current levels, says Sterne Agee
- Chico's FAS says sees FY SSS growth at mid-single digit rate
- Standard and Poor's Depository Receipts: Pivot points
BioHealth Investor Headlines
- Shouldn’t VIVUS Raise Capital Now? (VVUS)
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
WalletPop Headlines
- Hollywood, Homeland Security Double Up Video Piracy Warnings
- GM Kills $10 Million Facebook Ad Campaign Because It Didn't Work
- Saver or Sensualist, Innocent or Vigilant: What's Your Money Type?
- ExxonMobil's Safety Obsession: Inside the Mind of an Oil Giant
- Best Buy Gets Worse: CEO Dunn May Be Done, but His Payday Isn't
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
GM Kills $10 Million Facebook Ad Campaign Because It Didn't Work
PC Upgrades on Byte-Size Budgets -- Savings Experiment

